[NBIX] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
02-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -227.24%
YoY- -1,262.87%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 730 729 730 730 21,947 9,357 10,569 -83.08%
PBT -10,642 -11,131 -12,242 -12,075 9,490 -3,078 -501 662.73%
Tax -1,029 -880 -1,093 -898 -1,079 -884 -879 11.04%
NP -10,642 -11,131 -12,242 -12,075 9,490 -3,078 -501 662.73%
Tax Rate - - - - 11.37% - - -
Total Cost 11,372 11,860 12,972 12,805 12,457 12,435 11,070 1.80%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin -1,457.81 -1,526.89 -1,676.99 -1,654.11 43.24 -32.90 -4.74 4409.03%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS -0.16 -0.17 -0.18 -0.18 0.14 -0.05 -0.01 531.76%
EPS Diluted -0.16 -0.17 -0.18 -0.18 0.14 -0.05 -0.01 531.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.